vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Aterian, Inc. (ATER). Click either name above to swap in a different company.
Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $8.1M, roughly 1.9× Arcellx, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -766.0%, a 713.5% gap on every dollar of revenue. On growth, Aterian, Inc. posted the faster year-over-year revenue change (-38.5% vs -79.3%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-63.9M). Over the past eight quarters, Aterian, Inc.'s revenue compounded faster (-13.5% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
ACLX vs ATER — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $8.1M | $15.1M |
| Net Profit | $-62.3M | $-7.9M |
| Gross Margin | — | 56.1% |
| Operating Margin | -847.6% | -51.1% |
| Net Margin | -766.0% | -52.5% |
| Revenue YoY | -79.3% | -38.5% |
| Net Profit YoY | -765.1% | -512.2% |
| EPS (diluted) | $-1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $15.1M | ||
| Q3 25 | — | $19.0M | ||
| Q2 25 | — | $19.5M | ||
| Q1 25 | $8.1M | $15.4M | ||
| Q4 24 | $15.3M | $24.6M | ||
| Q3 24 | $26.0M | $26.2M | ||
| Q2 24 | $27.4M | $28.0M | ||
| Q1 24 | $39.3M | $20.2M |
| Q4 25 | — | $-7.9M | ||
| Q3 25 | — | $-2.3M | ||
| Q2 25 | — | $-4.9M | ||
| Q1 25 | $-62.3M | $-3.9M | ||
| Q4 24 | $-47.1M | $-1.3M | ||
| Q3 24 | $-25.9M | $-1.8M | ||
| Q2 24 | $-27.2M | $-3.6M | ||
| Q1 24 | $-7.2M | $-5.2M |
| Q4 25 | — | 56.1% | ||
| Q3 25 | — | 56.1% | ||
| Q2 25 | — | 54.3% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 63.4% | ||
| Q3 24 | — | 60.3% | ||
| Q2 24 | — | 60.4% | ||
| Q1 24 | — | 65.1% |
| Q4 25 | — | -51.1% | ||
| Q3 25 | — | -10.7% | ||
| Q2 25 | — | -23.1% | ||
| Q1 25 | -847.6% | -24.1% | ||
| Q4 24 | -348.2% | -6.5% | ||
| Q3 24 | -129.1% | -6.6% | ||
| Q2 24 | -127.8% | -11.5% | ||
| Q1 24 | -40.3% | -26.1% |
| Q4 25 | — | -52.5% | ||
| Q3 25 | — | -12.0% | ||
| Q2 25 | — | -25.0% | ||
| Q1 25 | -766.0% | -25.4% | ||
| Q4 24 | -308.4% | -5.3% | ||
| Q3 24 | -99.4% | -6.8% | ||
| Q2 24 | -99.3% | -13.0% | ||
| Q1 24 | -18.3% | -25.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-1.13 | — | ||
| Q4 24 | $-0.87 | — | ||
| Q3 24 | $-0.48 | — | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $4.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $15.2M |
| Total Assets | $648.1M | $29.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.9M | ||
| Q3 25 | — | $7.6M | ||
| Q2 25 | — | $10.5M | ||
| Q1 25 | $543.3M | $14.3M | ||
| Q4 24 | $587.4M | $18.0M | ||
| Q3 24 | $574.3M | $16.1M | ||
| Q2 24 | $516.7M | $20.3M | ||
| Q1 24 | $573.9M | $17.5M |
| Q4 25 | — | $15.2M | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | — | $24.3M | ||
| Q1 25 | $416.9M | $27.0M | ||
| Q4 24 | $454.8M | $30.0M | ||
| Q3 24 | $483.0M | $30.6M | ||
| Q2 24 | $487.2M | $30.9M | ||
| Q1 24 | $496.6M | $33.0M |
| Q4 25 | — | $29.6M | ||
| Q3 25 | — | $40.1M | ||
| Q2 25 | — | $45.4M | ||
| Q1 25 | $648.1M | $49.8M | ||
| Q4 24 | $711.3M | $49.5M | ||
| Q3 24 | $764.9M | $52.1M | ||
| Q2 24 | $734.3M | $59.9M | ||
| Q1 24 | $779.7M | $55.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $-1.0M |
| Free Cash FlowOCF − Capex | $-63.9M | $-1.0M |
| FCF MarginFCF / Revenue | -786.4% | -6.9% |
| Capex IntensityCapex / Revenue | 9.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.0M | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | $-63.1M | $-3.9M | ||
| Q4 24 | $-46.0M | $-9.0K | ||
| Q3 24 | $30.7M | $-722.0K | ||
| Q2 24 | $-36.2M | $2.9M | ||
| Q1 24 | $-31.9M | $-6.0K |
| Q4 25 | — | $-1.0M | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | $-63.9M | — | ||
| Q4 24 | $-47.5M | — | ||
| Q3 24 | $28.4M | — | ||
| Q2 24 | $-39.5M | $2.9M | ||
| Q1 24 | $-38.3M | $-42.0K |
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -8.4% | ||
| Q2 25 | — | -22.7% | ||
| Q1 25 | -786.4% | — | ||
| Q4 24 | -311.3% | — | ||
| Q3 24 | 109.2% | — | ||
| Q2 24 | -144.1% | 10.3% | ||
| Q1 24 | -97.7% | -0.2% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 9.6% | 0.0% | ||
| Q4 24 | 9.8% | 0.0% | ||
| Q3 24 | 8.8% | 0.0% | ||
| Q2 24 | 11.7% | 0.0% | ||
| Q1 24 | 16.4% | 0.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACLX
Segment breakdown not available.
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |